Company Analysis

Enovis Corporation (ENOV)

NYSE: ENOV · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Wilmington, DE · filing with the SEC since 2008
Grade5.0
◀ Past 5.4● Present 5.1▶ Future 4.5

Who owns Enovis Corporation

As filed with the SEC
Holders of 5% or more
5
Blackrock, Inc. holds 16% of Common Stock, as its SCHEDULE 13G/A filed Jul 28, 2026 says.
Directors and officers
19
report now, of 36 people on the record since 2008. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 5 named at left.
Holders of 5% or moreshare of the class, as filed
Blackrock, Inc.
SCHEDULE 13G/A · filed Jul 28, 2026 · Common Stock · 14.9% in Jul 17, 2025
16%
American Century Investment Management, Inc.
SCHEDULE 13G/A · filed Jul 8, 2026 · Common Stock · 8.3% in Aug 14, 2025
10.6%
Vanguard Portfolio Management
6.82%
Rubric Capital Management LP
SCHEDULE 13G · filed Aug 14, 2026 · Common Stock, $0.001 par value per share
6.78%
Vanguard Capital Management
5.23%
Diamond Hill Capital Management Inc
SCHEDULE 13G · filed Feb 6, 2025 · Common Stock · reported falling below 5%, from 5.4% in Nov 13, 2024
under 5%
Dimensional Fund Advisors LP
SCHEDULE 13G/A · filed Jan 21, 2026 · Common Stock · reported falling below 5%
under 5%
DAVENPORT & Co LLC
SCHEDULE 13G/A · filed Aug 12, 2025 · COMMON STOCK · reported falling below 5%, from 5.8% in Feb 5, 2025
under 5%
The Vanguard Group
SCHEDULE 13G/A · filed Mar 26, 2026 · Common Stock · reported falling below 5%, from 10.7% in Feb 7, 2025
under 5%
T. Rowe Price Investment Management, Inc.
SCHEDULE 13G/A · filed Jul 8, 2025 · COMMON STOCK · reported falling below 5%, from 10.9% in May 14, 2025
under 5%
What ENOV reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
LimaCorporate S.p.A.
A company bought · acquisition · Dec 2023 · owns, named in the 10-K filed Feb 26, 2026
Novastep
A company bought · acquisition · owns, named in the 10-K filed Feb 26, 2026

86 subsidiaries in 32 countries, from the list filed with the 10-K filed Feb 26, 2026.

Insider tradesForm 4
4sales
24purchases
0sales on a scheduled plan
1people selling
$0sold, in dollars
$900,000bought, in dollars
Open-market trades on Form 4 from Nov 12, 2025 to Nov 12, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
16171819202122232526
2026 runs to Nov 12, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window6 of 37 on the roster
PersonRole as filedSalesSoldOn a planBuysBought
Engert OliverChief Administrative Officer0$0016$400,000
Wienbar Sharon Ldirector0$004$100,000
Lalor Angela Sdirector0$002$100,000
Mcdonald DamienChief Executive Officer0$001$200,000
Kleckner JohnPrincipal Accounting Officer0$001$100,000
Pryor Daniel AEVP, Strategy & Business Dev.4$000$0
SI Assistanton ENOV · research, not advice